Showing 2871-2880 of 5685 results for "".
- EyeMD EMR Healthcare Systems to Debut its EyeMD Electronic Medical Records 2.0 Releasehttps://modernod.com/news/eyemd-to-debut-its-eyemd-electronic-medical-records-2-0-release/2479739/EyeMD EMR Healthcare Systems, a provider of electronic medical records software designed specifically for ophthalmologists, announced the debut of EyeMD EMR 2.0 at the 2018 American Academy of Ophthalmology’s Annual Meeting in Chicago. “EyeMD EMR 2.0 is the result of years of research and
- LumiThera and Optos Announce Collaboration to Commercialize the Valeda Light Delivery System for Treating Dry AMD in Europehttps://modernod.com/news/lumithera-and-optos-announce-collaboration-to-commercialize-the-valeda-light-delivery-system-for-treating-dry-amd-in-europe/2479740/LumiThera announced a distribution agreement with Optos to exclusively distribute the Valeda Light Delivery System for the treatment of dry age-related macular degeneration (AMD) in 12 European countries. The announcement follows the recent CE Mark certification for the European Union (EU) for th
- Eylea Meets Main Goals in Phase 3 Non-Proliferative Diabetic Retinopathy Studyhttps://modernod.com/news/eylea-injection-improves-diabetic-retinopathy-and-reduces-vision-threatening-complications-in-phase-3-trial/2479745/Regeneron Pharmaceuticals announced that the phase 3 PANORAMA trial evaluating Eylea (aflibercept) injection in patients with moderately severe and severe non-proliferative diabetic retinopathy (NPDR) met its 1-year (52-week) primary endpoint and key secondary endpoints. On the primary end
- Foundation Fighting Blindness Launches Retinal Degeneration Fundhttps://modernod.com/news/foundation-fighting-blindness-launches-retinal-degeneration-fund/2479747/The Foundation Fighting Blindness announced the creation of the first Retinal Degeneration Fund (RD Fund), a wholly owned, 501(c)(3) not-for-profit subsidiary focused on making venture philanthropy investments to furt
- Non-Contact Panretinal Photocoagulation for Navilas 577s Introduced at AAO 2018https://modernod.com/news/non-contact-panretinal-photocoagulation-for-navilas-577s-introduced-at-aao-2018/2479753/At the AAO 2018 meeting in Chicago, OD-OS is launching a new widefield objective which brings non-contact panretinal photocoagulation with access to the far periphery (ora serrata) to the Navilas 577s Laser System. The new option for peripheral treatments can further enhance compliance of sensiti
- Optos and Amydis Establish Clinical Alliance to Develop Early Diagnostic Test for Alzheimer’s Diseasehttps://modernod.com/news/optos-and-amydis-establish-clinical-alliance-to-develop-early-diagnostic-test-for-alzheimers-disease/2479754/Optos, a subsidiary of Nikon Corporation, and Amydis announced a clinical alliance focused on the development of an eye test by Amydis to detect Alzheimer’s disease. Amydis has developed a pipeline of compounds to detect amyloid proteins in the retina to be visualized with Optos’ optomap ultra-wi
- Carl Zeiss Meditec to Acquire IanTECH, Maker of the miLOOP Device for Cataract Surgeryhttps://modernod.com/news/carl-zeiss-meditec-to-acquire-iantech-maker-of-the-miloop-device-for-cataract-surgery/2479758/Carl Zeiss Meditec announced it has entered into an agreement to acquire IanTECH, the manufacturer of the miLOOP device for cataract surgery. miLOOP is a microinterventional device designed to deliver energy-free endocapsular lens fragmentation independent of phaco energy. Terms of the d
- Alcon to Develop SMART Suite Digital Health Platform for Cataract Surgeryhttps://modernod.com/news/alcon-to-develop-smart-suite-digital-health-platform-for-cataract-surgery/2479762/Alcon announced plans to develop the SMART Suite by Alcon, a digital platform that is designed to streamline, simplify, and improve cataract surgery for surgeons and patients. The SMART Suite by Alcon will connect multiple diagnostic and surgical devices through a digital, open cloud-based
- LEH Pharma Appoints Syneos Health as Global Clinical Development and Commercialization Solutions Providerhttps://modernod.com/news/leh-pharma-appoints-syneos-health-as-global-clinical-development-and-commercialization-solutions-provider/2479769/LEH Pharma, a provider of ocular implants for macular disorders, announced the selection of Syneos Health, a fully integrated biopharmaceutical solutions organization, as its global clinical development and commercialization provider. The primary aim of the strategic relationship is to acc
- Johnson & Johnson Vision Appoints Carol Alexander, OD, Head, North America Vision Care Professional Relationshttps://modernod.com/news/johnson-johnson-vision-appoints-carol-alexander-od-head-north-america-vision-care-professional-relations/2479774/Carol Alexander, OD, has been appointed Head, North America Vision Care Professional Relations for Johnson & Johnson Vision. In this role, Carol will work to strengthen the relationship between Johnson & Johnson Vision and the optometric community in the US, w